Cranial Irradiation and Acute Lymphocytic Leukemia (ALL): Understanding the Relationship

Cranial irradiation is not typically indicative of an acute lymphocytic leukemia (ALL) patient.

While cranial irradiation used to be a common component of treatment for ALL patients, particularly those with central nervous system (CNS) involvement, it is now less commonly used due to its potential long-term side effects, such as cognitive impairment and secondary malignancies.

Modern treatment protocols for ALL typically involve chemotherapy, targeted therapy, and hematopoietic stem cell transplantation (HSCT). These approaches have proven effective in achieving high cure rates while minimizing the need for cranial irradiation.